featured
Ublituximab Use in Patients With Relapsing MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 2 Multicenter Study of Ublituximab, a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Patients With Relapsing Forms of Multiple Sclerosis
Mult. Scler. 2020 Apr 30;[EPub Ahead of Print], E Fox, AE Lovett-Racke, M Gormley, Y Liu, M Petracca, S Cocozza, R Shubin, S Wray, MS Weiss, JA Bosco, SA Power, K Mok, M IngleseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.